A new study has pointed out that bacteria that produce compounds to reduce inflammation and boost host defences may help in the treatment of inflammatory bowel disease (IBD).
A new study has pointed out that bacteria that produce compounds to reduce inflammation and boost host defences may help in the treatment of inflammatory bowel disease (IBD).
According to researchers, such probiotic microbes could be the most successful treatment for IBD to date.
Inflammatory Bowel Disease Could be Tackled by Promising Probiotic Treatment
New research indicates that bacteria that produce compounds to reduce inflammation and strengthen host defences could be used to treat inflammatory bowel disease (IBD).
New research indicates that bacteria that produce compounds to reduce inflammation and strengthen host defences could be used to treat inflammatory bowel disease (IBD).
While the exact causes are unclear, IBD is known to be the result of an overactive immune response that is linked to an imbalance of the normal types of bacteria found in the gut.
Several recent studies have identified butyric acid as a potential therapeutic agent for IBD. Some gut bacteria produce butyric acid naturally in the intestines, but in IBD patients some of these strains are heavily depleted.
Imbalanced Immune System Cause of Inflammatory Bowel Disease Found
A critical imbalance of the regulatory cells required to control the immune system might make a person more prone to inflammatory bowel disease: Study from University of Adelaide.
A critical imbalance of the regulatory cells required to control the immune system might make a person more prone to inflammatory bowel disease: Study from University of Adelaide.
In addition, novel identified butyrate-producing strains, such as Butyricicoccus pullicaecorum, have been shown to exert similar effects.
Advertisement
Inflammatory Bowel Disease Worsened by CMV Infection
Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD).
Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD).
In addition to butyric acid, it is hypothesized that strains such as F. prausnitzii and B.pullicaecorum secrete other anti-inflammatory compounds that may enhance the therapeutic effect.
Advertisement
New Findings May Lead To Improved Therapies For Inflammatory Bowel Disease
An international team of researchers has discovered an enzyme that plays a crucial role in inflammatory bowel disease (IBD).
An international team of researchers has discovered an enzyme that plays a crucial role in inflammatory bowel disease (IBD).
"Conventional drug therapy has limited effectiveness and considerable side effects. Probiotics are live bacterial supplements or food ingredients, which when taken in sufficient numbers confer health benefits to the host," he said.
The study has been published in the February issue of the Journal of Medical Microbiology.
Source-ANI
SAV
